Medicine
Venclexta 100 mg tablet
Venclexta 100 mg tablet is a prescription medicine containing Venetoclax for oral use, marketed by AbbVie, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store in original container at or below 86°F (30°C). Dispense to patient in…
Key facts
- Active ingredient (INN)
- Venetoclax
- Brand
- Venclexta
- Strength
- 100 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 1 blister pack, 120 tablets, 1 bottle
- Marketing authorisation holder
- AbbVie
- Manufacturer
- AbbVie
- Origin register
- US FDA, United States
- Storage
- Store in original container at or below 86°F (30°C). Dispense to patient in original container to protect from moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01XX52 Venetoclax
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 11 April 2016
- Identifiers
- RxCUI 1747561, 1747567, 1747572 +5DailyMed set ID b118a40d-6b56-cee3-10f6-ded821a97018NDC 0074-0576Application NDA208573
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Venetoclax
Clinical summary
Venetoclax is a BCL-2 inhibitor indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), among other approved uses. It is available as tablets and kits for oral use. MedsAcross supplies Venetoclax for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about VenetoclaxFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Venclexta prescribing information (AbbVie) · U.S. National Library of Medicine, DailyMed
- Venclyxto: European public assessment report (EPAR) · European Medicines Agency
Need Venclexta 100 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.